FilingReader Intelligence
Hansoh Pharmaceutical cuts convertible bond conversion price
August 18, 2025 at 01:11 PM UTC•By FilingReader AI
Hansoh Pharmaceutical Group has cut the conversion price on its $600m zero coupon convertible bonds due 2026 from HK$57.48 to HK$56.70 per share, effective September 26, 2025.
The adjustment follows an interim dividend payment. Outstanding principal totals $5.38m.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:3692•Hong Kong Exchange
News Alerts
Get instant email alerts when Hansoh Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime